These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 12469325

  • 1. The proto-oncogene BCL-6 in normal and malignant B cell development.
    Niu H.
    Hematol Oncol; 2002 Dec; 20(4):155-66. PubMed ID: 12469325
    [Abstract] [Full Text] [Related]

  • 2. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.
    Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP, Dalla-Favera R.
    Nat Genet; 1997 Jun; 16(2):161-70. PubMed ID: 9171827
    [Abstract] [Full Text] [Related]

  • 3. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT, Dalla-Favera R.
    Nature; 2004 Dec 02; 432(7017):635-9. PubMed ID: 15577913
    [Abstract] [Full Text] [Related]

  • 4. Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
    Jardin F, Sahota SS.
    Hematology; 2005 Apr 02; 10(2):115-29. PubMed ID: 16019457
    [Abstract] [Full Text] [Related]

  • 5. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E, Malecka A, Myklebust JH, Tierens A, Aasheim HC, Nesland JM, Smeland E, Kvaløy S, Delabie J.
    J Pathol; 2005 Jul 02; 206(3):312-9. PubMed ID: 15892171
    [Abstract] [Full Text] [Related]

  • 6. Induction of BCL-6 gene expression by interferon-gamma and identification of an IRE in exon I.
    Zhou G, Ono SJ.
    Exp Mol Pathol; 2005 Feb 02; 78(1):25-35. PubMed ID: 15596057
    [Abstract] [Full Text] [Related]

  • 7. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
    Kurata M, Maesako Y, Ueda C, Nishikori M, Akasaka T, Uchiyama T, Ohno H.
    Cancer Res; 2002 Nov 01; 62(21):6224-30. PubMed ID: 12414651
    [Abstract] [Full Text] [Related]

  • 8. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas.
    Pittaluga S, Ayoubi TA, Wlodarska I, Stul M, Cassiman JJ, Mecucci C, Van Den Berghe H, Van De Ven WJ, De Wolf-Peeters C.
    J Pathol; 1996 Jun 01; 179(2):145-50. PubMed ID: 8758205
    [Abstract] [Full Text] [Related]

  • 9. Acetylation inactivates the transcriptional repressor BCL6.
    Bereshchenko OR, Gu W, Dalla-Favera R.
    Nat Genet; 2002 Dec 01; 32(4):606-13. PubMed ID: 12402037
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional repressor BCL-6 immortalizes germinal center-like B cells in the absence of p53 function.
    Kusam S, Vasanwala FH, Dent AL.
    Oncogene; 2004 Jan 22; 23(3):839-44. PubMed ID: 14737119
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre (GC) phenotype and bcl-2 expression in patients with diffuse large B-cell lymphoma.
    Pedersen LM, Jürgensen GW, Johnsen HE.
    Br J Haematol; 2005 Mar 22; 128(6):813-9. PubMed ID: 15755285
    [Abstract] [Full Text] [Related]

  • 12. [Bcl-6: a protooncogene co-involved in B-lymphocyte differentiation and in the pathogenesis of diffuse, large-cell non-Hodgkin's lymphomas of the B phenotype].
    Pescarmona E.
    Pathologica; 1998 Feb 22; 90(1):81-2. PubMed ID: 9628984
    [No Abstract] [Full Text] [Related]

  • 13. BCL-6 in diffuse large-cell lymphomas.
    Dalla-Favera R, Ye BH, Cattoretti G, Lo Coco F, Chang CC, Zhang J, Migliazza A, Cechova K, Niu H, Chaganti S, Chen W, Louie DC, Offit K, Chaganti RS.
    Important Adv Oncol; 1996 Feb 22; ():139-48. PubMed ID: 8791133
    [No Abstract] [Full Text] [Related]

  • 14. Ambivalent role of BCL6 in cell survival and transformation.
    Albagli-Curiel O.
    Oncogene; 2003 Jan 30; 22(4):507-16. PubMed ID: 12555064
    [Abstract] [Full Text] [Related]

  • 15. BCL-6 regulates chemokine gene transcription in macrophages.
    Toney LM, Cattoretti G, Graf JA, Merghoub T, Pandolfi PP, Dalla-Favera R, Ye BH, Dent AL.
    Nat Immunol; 2000 Sep 30; 1(3):214-20. PubMed ID: 10973278
    [Abstract] [Full Text] [Related]

  • 16. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.
    Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R.
    Nat Immunol; 2005 Oct 30; 6(10):1054-60. PubMed ID: 16142238
    [Abstract] [Full Text] [Related]

  • 17. BCL-6: rearrangement and mutation in lymphoma.
    Wagner SD, Kaeda JS.
    Methods Mol Med; 2005 Oct 30; 115():251-70. PubMed ID: 15998973
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis.
    Albagli-Curiel O, Dhordain P, Lantoine D, Auradé F, Quief S, Kerckaert JP, Montarras D, Pinset C.
    Differentiation; 1998 Nov 30; 64(1):33-44. PubMed ID: 9921651
    [Abstract] [Full Text] [Related]

  • 19. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation.
    Fujita N, Jaye DL, Geigerman C, Akyildiz A, Mooney MR, Boss JM, Wade PA.
    Cell; 2004 Oct 01; 119(1):75-86. PubMed ID: 15454082
    [Abstract] [Full Text] [Related]

  • 20. Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci.
    Albagli O, Lantoine D, Quief S, Quignon F, Englert C, Kerckaert JP, Montarras D, Pinset C, Lindon C.
    Oncogene; 1999 Sep 09; 18(36):5063-75. PubMed ID: 10490843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.